Publication | Closed Access

Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial

ThrombosisCardiovascular DiseaseMedicineCardiovascular PharmacologyP2y12 InhibitionPharmacotherapyAcute Myocardial InfarctionPublic HealthPlatelet AntagonistPharmacologyAnticoagulantCardiologyAcute Coronary SyndromesCoronary Artery DiseaseAnesthesiology